These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9637143)

  • 1. Short-term effects of population-based screening for prostate cancer on health-related quality of life.
    Essink-Bot ML; de Koning HJ; Nijs HG; Kirkels WJ; van der Maas PJ; Schröder FH
    J Natl Cancer Inst; 1998 Jun; 90(12):925-31. PubMed ID: 9637143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of prostate cancer screening in The Netherlands: assessment of acceptance and motives for attendance.
    Nijs HG; Tordoir DM; Schuurman JH; Kirkels WJ; Schröder FH
    J Med Screen; 1997; 4(2):102-6. PubMed ID: 9275269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
    Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
    BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores.
    Naughton CK; Miller DC; Yan Y
    J Urol; 2001 Jan; 165(1):100-3. PubMed ID: 11125374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do men refuse or attend population-based screening for prostate cancer?
    Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
    J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC).
    Vasarainen H; Malmi H; Määttänen L; Ruutu M; Tammela T; Taari K; Rannikko A; Auvinen A
    Acta Oncol; 2013 Nov; 52(8):1615-21. PubMed ID: 23786174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial interventions for men with prostate cancer.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008529. PubMed ID: 24368598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.
    Drummond FJ; Kinnear H; Donnelly C; O'Leary E; O'Brien K; Burns RM; Gavin A; Sharp L
    BMJ Open; 2015 Apr; 5(4):e006851. PubMed ID: 25888474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
    Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
    BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
    J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and distress during active surveillance for early prostate cancer.
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
    Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.
    Venderbos LDF; Aluwini S; Roobol MJ; Bokhorst LP; Oomens EHGM; Bangma CH; Korfage IJ
    Qual Life Res; 2017 Jun; 26(6):1635-1645. PubMed ID: 28168601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
    Essink-Bot ML; Korfage IJ; De Koning HJ
    BJU Int; 2003 Dec; 92 Suppl 2():101-5. PubMed ID: 14983965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring prostate cancer survivors' self-management behaviours and examining the mechanism effect that links coping and social support to health-related quality of life, anxiety and depression: a prospective longitudinal study.
    Paterson C; Robertson A; Nabi G
    Eur J Oncol Nurs; 2015 Apr; 19(2):120-8. PubMed ID: 25497067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
    Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
    BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life of men treated with brachytherapies for prostate cancer.
    Lev EL; Eller LS; Gejerman G; Lane P; Owen SV; White M; Nganga N
    Health Qual Life Outcomes; 2004 Jun; 2():28. PubMed ID: 15198803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials.
    Mendoza TR; Dueck AC; Shi Q; Ma H; Zhang J; Qian Y; Cleeland CS
    Eur J Pain; 2018 Mar; 22(3):565-571. PubMed ID: 29082574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
    Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
    Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.